| No. |
DrugBank |
Drug (Description in trials)
[Number of descriptions] |
KEGG DRUG * | KEGG GENES *
[Number of genes] |
KEGG PATHWAY
[Number of pathways] |
Disease ID *
[Number of diseases] |
| 1 | Cysteamine | [9] Cystagon (cysteamine bitartrate) immediate-release capsules; Cystagon® (cysteamine bitartrate); Cysteamine; Cysteamine (mercaptamine) viscous solution; Cysteamine bitartrate; Cysteamine bitartrate (cystagon); Cysteamine bitartrate (inn: mercaptamine bitartrate ); Cysteamine bitartrate delayed-release capsules (rp103); Cysteamine hydrochloride; | D03634
D03635 |
- |
- |
[4] 8, 19, 21, 299 |
| 2 | Dexmedetomidine | [8] Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Dexmedetomidine and fentanyl; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine hydrochloride infusion; | D00514
D01205 |
[3] ADRA2A, ADRA2B, ADRA2C |
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
[11] 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
| 3 | Elamipretide | [1] Elamipretide; | D10925 |
- |
- |
[2] 21, 324 |
| 4 | Propofol | [3] Intubated with propofol (ip); Propofol; Propofol-lipuro; | D00549 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 5 | Sevoflurane | [3] Intubated with sevoflurane (is); Sevoflurane; Sevoflurane anesthetics; | D00547 |
- |
- |
[5] 6, 21, 22, 98, 296 |
| 6 | Uridine triacetate | - | D09985 |
- |
- |
[1] 21 |